May 16, 2025

finance  
Read News
Pathos AI $365M, Harvey AI $250M, AI Trading, Life Science Analytics, Amazon, Nvidia

Recent developments in the field of artificial intelligence have seen significant investments and advancements. Pathos AI has raised $365 million to develop new cancer drugs using AI, with the goal of transforming drug development by harnessing the full potential of multimodal data and AI. Meanwhile, Harvey AI is in talks to raise over $250 million in funding at a valuation of $5 billion, with plans to expand its offerings and develop new AI models. The use of AI in trading is also changing the way trades are made and profits are generated, with AI-powered trade systems able to process large amounts of data and make decisions quickly. In the life science analytics market, AI is projected to reach $3.6 billion by 2030, driven by the increasing adoption of AI and machine learning in life sciences. Additionally, companies like Amazon and Nvidia are making significant strides in the AI stock market, with Amazon's cloud computing segment potentially surpassing Nvidia's value by 2030. Other notable developments include the launch of Quanttrix.io, India's smartest AI trading bot, and the growth of The Trade Desk's AI-powered programmatic ad platform, Kokai.

Key Takeaways

  • Pathos AI has raised $365 million to develop new cancer drugs using artificial intelligence.
  • Harvey AI is in talks to raise over $250 million in funding at a valuation of $5 billion.
  • The use of AI in trading is changing the way trades are made and profits are generated.
  • The global AI in life science analytics market is projected to reach $3.6 billion by 2030.
  • Amazon's cloud computing segment may surpass Nvidia's value in the AI stock market by 2030.
  • Quanttrix.io has launched India's smartest AI trading bot, using AI to analyze market data and detect profitable opportunities.
  • The Trade Desk's AI-powered programmatic ad platform, Kokai, is gaining traction with two-thirds of clients already using it.
  • AI-powered trade systems can process large amounts of data and make decisions quickly, but human traders still have an advantage in certain areas.
  • The increasing adoption of AI and machine learning in life sciences is driving growth in the life science analytics market.
  • AI is being used to improve clinical trials and accelerate drug development in the pharmaceutical industry.

Pathos AI raises $365M for cancer drug development

Pathos AI has raised $365 million in funding to develop new cancer drugs using artificial intelligence. The company's platform, PathOS, uses AI to analyze data and identify ways to improve clinical trials. Pathos AI is currently running trials for two cancer drugs and plans to use the funding to finance its clinical studies and develop its AI model. The company's goal is to transform drug development by harnessing the full potential of multimodal data and AI.

Pathos AI closes $365M investment for AI-powered drug development

Pathos AI has closed a $365 million investment round to develop new oncology drugs using artificial intelligence. The company's platform uses AI to assist pharmaceutical scientists and has partnered with companies like AstraZeneca and Tempus AI. Pathos AI plans to use the funding to finance its clinical studies and develop its AI model, which can process multimodal clinical, molecular, and imaging data. The company's goal is to accelerate drug development and improve clinical trials.

Harvey AI in talks to raise funding at $5 billion valuation

Harvey AI, a legal startup, is in talks to raise over $250 million in funding at a valuation of $5 billion. The company uses AI models and machine-learning algorithms to assist lawyers and legal professionals. Harvey AI has partnered with companies like PwC and has seen significant revenue growth, with its annualized run rate reaching $75 million in April. The company plans to use the funding to expand its offerings and develop new AI models.

Pony AI CFO discusses partnership with Uber in Middle East

Pony AI's CFO has discussed the company's partnership with Uber in the Middle East. Unfortunately, the article content is not available, so more information cannot be provided.

AI trading vs human traders in crypto market

The use of artificial intelligence in trading is changing the way trades are made and profits are generated. AI-powered trade systems can process large amounts of data and make decisions quickly, but human traders still have an advantage in certain areas, such as interpreting unstructured events and accounting for geopolitical risk. A hybrid model that combines human judgment with AI tools may be the most effective approach. AI trading has been successful in crypto markets, where prices can vary rapidly, and has helped traders to make more informed decisions.

Amazon may surpass Nvidia in AI stock value by 2030

Amazon's cloud computing segment, Amazon Web Services (AWS), may surpass Nvidia's value in the AI stock market by 2030. AWS has a dominant market share and high profit margins, and its growth is driven by the increasing demand for cloud computing and AI. Nvidia's market share in data center GPUs is expected to decline due to increasing competition, which may lead to lower gross margins. Amazon's valuation could exceed Nvidia's based on its cloud segment's long-term success.

AI in life science analytics market to reach $3.6 billion by 2030

The global AI in life science analytics market is projected to reach $3.6 billion by 2030, growing at a CAGR of 10.9%. The market is driven by the increasing adoption of AI and machine learning in life sciences, particularly in diagnostics, real-world evidence generation, and personalized healthcare. The use of AI in life science analytics enables faster and more economical methods for discovering and developing new drugs, and improves the accuracy and speed of diagnostic tools.

3 AI stocks that may plunge up to 92% according to analysts

Unfortunately, the article content is not available, so more information cannot be provided.

The Trade Desk stock down 32% may be a good buy

The Trade Desk's stock has fallen 32% in 2025, but the company's Q1 results show promising growth, with revenue increasing 25% year-over-year. The company's AI-powered programmatic ad platform, Kokai, is gaining traction, with two-thirds of clients already using it. The Trade Desk expects all clients to be using Kokai by the end of the year, which could lead to further growth and increased demand for the company's services.

Quanttrix launches India's smartest AI trading bot

Quanttrix.io is a new AI-powered algorithmic trading platform launched in India. The platform uses AI to analyze market data and detect profitable opportunities, and enables traders to automate their strategies with precision. Quanttrix.io offers features such as AI-powered market insights, automated trading execution, and advanced risk management. The platform is designed to support high-frequency trading for both individuals and financial institutions, and aims to democratize AI-powered trading in India.

Sources

Artificial Intelligence AI in Healthcare Cancer Drug Development AI-Powered Trading Machine Learning AI in Life Sciences